306 related articles for article (PubMed ID: 8676627)
1. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.
Axworthy D; Brock DJ; Bobrow M; Marteau TM
Lancet; 1996 May; 347(9013):1443-6. PubMed ID: 8676627
[TBL] [Abstract][Full Text] [Related]
2. The impact of population based screening for carriers of cystic fibrosis.
Bekker H; Denniss G; Modell M; Bobrow M; Marteau T
J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women?
Mennie ME; Axworthy D; Liston WA; Brock DJ
Prenat Diagn; 1997 Sep; 17(9):853-60. PubMed ID: 9316130
[TBL] [Abstract][Full Text] [Related]
4. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
[TBL] [Abstract][Full Text] [Related]
5. Population screening for cystic fibrosis: knowledge and emotional consequences 18 months later.
Gordon C; Walpole I; Zubrick SR; Bower C
Am J Med Genet A; 2003 Jul; 120A(2):199-208. PubMed ID: 12833400
[TBL] [Abstract][Full Text] [Related]
6. [A follow-up study of carriers of cystic fibrosis].
Brandt NJ; Schwartz M; Skovby F; Clausen H
Ugeskr Laeger; 1996 Aug; 158(33):4623-7. PubMed ID: 8760517
[TBL] [Abstract][Full Text] [Related]
7. Whole-population screening for carriers of cystic fibrosis gene.
Carswell F
Lancet; 1996 May; 347(9013):1421-2. PubMed ID: 8676620
[No Abstract] [Full Text] [Related]
8. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis carrier testing in early pregnancy by general practitioners.
Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
BMJ; 1993 Jun; 306(6892):1580-3. PubMed ID: 8329921
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners.
Mennie ME; Compton ME; Gilfillan A; Liston WA; Pullen I; Whyte DA; Brock DJ
J Med Genet; 1993 Jul; 30(7):543-8. PubMed ID: 8411025
[TBL] [Abstract][Full Text] [Related]
11. Psychological and social impact of carrier screening for cystic fibrosis among pregnant woman--a pilot study.
Clausen H; Brandt NJ; Schwartz M; Skovby F
Clin Genet; 1996 Apr; 49(4):200-5. PubMed ID: 8828986
[TBL] [Abstract][Full Text] [Related]
12. Patient and parental attitudes toward genetic screening and its implications at an adult cystic fibrosis centre.
Conway SP; Allenby K; Pond MN
Clin Genet; 1994 Jun; 45(6):308-12. PubMed ID: 7923862
[TBL] [Abstract][Full Text] [Related]
13. Psychological impact of carrier screening for cystic fibrosis among pregnant women.
Clausen H; Brandt NJ; Schwartz M; Skovby F
Eur J Hum Genet; 1996; 4(2):120-3. PubMed ID: 8744031
[TBL] [Abstract][Full Text] [Related]
14. Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender.
Marteau TM; Dundas R; Axworthy D
Health Psychol; 1997 Jan; 16(1):51-62. PubMed ID: 9028815
[TBL] [Abstract][Full Text] [Related]
15. Psychological and social consequences of community carrier screening programme for cystic fibrosis.
Watson EK; Mayall ES; Lamb J; Chapple J; Williamson R
Lancet; 1992 Jul; 340(8813):217-20. PubMed ID: 1353144
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
Jung U; Urner U; Grade K; Coutelle C
Hum Genet; 1994 Jul; 94(1):19-24. PubMed ID: 8034290
[TBL] [Abstract][Full Text] [Related]
17. Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands.
Lakeman P; Plass AM; Henneman L; Bezemer PD; Cornel MC; ten Kate LP
Genet Med; 2008 Nov; 10(11):820-30. PubMed ID: 18941425
[TBL] [Abstract][Full Text] [Related]
18. Incorrect recall of residual risk three years after carrier screening for cystic fibrosis: a comparison of two-step and couple screening.
Marteau TM; Michie S; Miedzybrodzka ZH; Allanson A
Am J Obstet Gynecol; 1999 Jul; 181(1):165-9. PubMed ID: 10411814
[TBL] [Abstract][Full Text] [Related]
19. Population screening for cystic fibrosis in Western Australia: community response.
Honnor M; Zubrick SR; Walpole I; Bower C; Goldblatt J
Am J Med Genet; 2000 Jul; 93(3):198-204. PubMed ID: 10925381
[TBL] [Abstract][Full Text] [Related]
20. Carrier screening for cystic fibrosis: test acceptance and one year follow-up.
Levenkron JC; Loader S; Rowley PT
Am J Med Genet; 1997 Dec; 73(4):378-86. PubMed ID: 9415462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
